Literature DB >> 10781011

Behavioural and physiological effects induced by an infusion of antisense to alpha(2D)-adrenoceptors in the rat.

E S Robinson1, D J Nutt, H C Jackson, A L Hudson.   

Abstract

1. The aim of this study was to investigate the behavioural and physiological effects of an i.c.v. infusion of antisense oligonucleotide to the alpha(2D)-adrenoceptor subtype. Behavioural and physiological parameters were monitored for 2 days before the infusion, throughout the 3-day infusion period and for 3 days following the end of the infusion. 2. The antisense infusion resulted in a significant increase in behavioural activity characterized by increased locomotion and grooming scores. Behavioural activity scores of rats treated with antisense to alpha(2D)-adrenoceptors were significantly higher than those of rats treated with vehicle (H(2)O) or the mismatch toxicity control on day 4 and day 5 and, significantly higher than vehicle controls on day 6. 3. Body weight gain was significantly reduced in the antisense-treated rats at the end of the study compared to the vehicle (34%) and mismatch groups (30%), although daily food and water intakes were not significantly different at any time point. 4. Pupil diameters of rats infused with antisense to alpha(2D)-adrenoceptors were significantly greater than those of animals treated either with vehicle or mismatch oligonucleotide on day 5 of the study. On day 6, the pupil diameters of these animals were still significantly greater than the mismatch group. 5. In conclusion, an i.c.v. infusion of antisense to the alpha(2D)-adrenoceptor induced behavioural activation in rats, increased pupil diameter and reduced total weight gain. These effects were specific to the antisense-treated group and were fully reversed post-infusion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781011      PMCID: PMC1572045          DOI: 10.1038/sj.bjp.0703296

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

Review 1.  25 years since the discovery of presynaptic receptors: present knowledge and future perspectives.

Authors:  S Z Langer
Journal:  Trends Pharmacol Sci       Date:  1997-03       Impact factor: 14.819

Review 2.  Alpha 2-adrenoceptors and I2 sites in the mammalian central nervous system.

Authors:  N French
Journal:  Pharmacol Ther       Date:  1995       Impact factor: 12.310

Review 3.  Noradrenergic mechanisms in the prefrontal cortex.

Authors:  D J Nutt; M D Lalies; L A Lione; A L Hudson
Journal:  J Psychopharmacol       Date:  1997       Impact factor: 4.153

4.  Critical issues in the antisense inhibition of brain gene expression in vivo: experiences targetting the 5-HT1A receptor.

Authors:  S M Le Corre; P W Burnet; R Meller; T Sharp; P J Harrison
Journal:  Neurochem Int       Date:  1997-09       Impact factor: 3.921

5.  Catecholamine receptors on locus coeruleus neurons: pharmacological characterization.

Authors:  J M Cedarbaum; G K Aghajanian
Journal:  Eur J Pharmacol       Date:  1977-08-15       Impact factor: 4.432

6.  The effects of idazoxan and other alpha 2-adrenoceptor antagonists on food and water intake in the rat.

Authors:  H C Jackson; I J Griffin; D J Nutt
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

7.  Subclassification of presynaptic alpha 2-adrenoceptors: alpha 2D-autoreceptors in mouse brain.

Authors:  N Limberger; A U Trendelenburg; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

8.  Presynaptic alpha 2-autoreceptors in brain cortex: alpha 2D in the rat and alpha 2A in the rabbit.

Authors:  A U Trendelenburg; N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

9.  Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.

Authors:  A Renouard; P S Widdowson; M J Millan
Journal:  J Pharmacol Exp Ther       Date:  1994-09       Impact factor: 4.030

10.  Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals.

Authors:  K Xu; L Näveri; K U Frerichs; J M Hallenbeck; G Feuerstein; J N Davis; A L Sirén
Journal:  J Pharmacol Exp Ther       Date:  1993-10       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.